Comparative Efficacy and Safety of Augmentation Therapy with Ziprasidone versus Quetiapine in Patients of Major Depressive Disorder on Escitalopram| Chapter 4 | Current Aspects in Pharmaceutical Research and Development Vol.9
Many patients with major depressive disorder (MDD) do not respond to traditional antidepressant medication or only respond partially. As a result, augmentation therapy with atypical antipsychotic medications is required in many patients, boosting antidepressant effect and extending partial remission. In
Read More